Scherak O, Smolen J S, Mayr W R, Mayrhofer F, Kolarz G, Thumb N J
J Rheumatol. 1984 Oct;11(5):610-4.
One hundred sixty-eight patients with rheumatoid arthritis treated with chloroquine (n = 87), gold salts (n = 133) and/or penicillamine (n = 77) were investigated for possible associations between HLA antigens and toxic reactions. Patients with 2 or more side effects to gold and/or penicillamine had a significantly increased frequency of antigens HLA-B8 and DR3 compared to patients with one or without adverse reactions. Proteinuria to gold or penicillamine was significantly associated with HLA-B8 (relative risk [RR] 4.2) and DR3 (RR 14.0) whereas nonnephrologic side effects to gold or penicillamine were associated with B7 and DR2 (RR 3.5 and 2.8). Patients with skin reactions to gold had a significantly greater frequency of HLA-B7. We found no correlation between chloroquine side effects and any HLA antigen. The results suggest a genetic predisposition to toxic reactions to gold or penicillamine based on an immunologic dysregulation.
对168例接受氯喹(n = 87)、金盐(n = 133)和/或青霉胺(n = 77)治疗的类风湿性关节炎患者,研究了HLA抗原与毒性反应之间可能存在的关联。与有1种或无不良反应的患者相比,对金盐和/或青霉胺有2种或更多副作用的患者,抗原HLA - B8和DR3的频率显著增加。金盐或青霉胺所致蛋白尿与HLA - B8(相对危险度[RR] 4.2)和DR3(RR 14.0)显著相关,而金盐或青霉胺的非肾脏副作用与B7和DR2相关(RR分别为3.5和2.8)。对金盐有皮肤反应的患者,HLA - B7的频率显著更高。我们未发现氯喹副作用与任何HLA抗原之间存在相关性。结果提示,基于免疫调节异常,对金盐或青霉胺的毒性反应存在遗传易感性。